As last year, we were present in Biofit. This congress is one of the best european place to be for B2B meetings. I had around 20 B to B meetings to discuss partnering and business, with biotech companies, other CROs and with public transfert technology societies as SATT in France or ErasmusMC in The Netherlands. That I can observe is that B2B meetings with pharmaceutical industries are increasingly turned to partnering around drugs already in clinical development rather than business around innovative projects. Nevertheless, it was a good place to discuss partnering with others CROs and biotech companies.
english
Importance of extracellular matrix for neuronal cell growth
Sood et al. published in 2016 an interesting article about the effect of extracellular matrix (ECM) on in vitro neuronal cells culture: “Fetal brain extracellular matrix boosts neuronal network formation in 3D bioengineered model of Read more…
